(Q34531396)

2 August 2017

1 reference

title

Herpes simplex virus resistance to antiviral drugs (English)

1 reference

2 August 2017

0 references

Florence Morfin

1

1 reference

2 August 2017

Danielle Thouvenot

series ordinal

2

1 reference

2 August 2017

publication date

1 January 2003

1 reference

Journal of Clinical Virology

2 August 2017

published in

1 reference

2 August 2017

volume

26

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

29-37

1 reference

Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Analysis of the thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

The role of herpes simplex virus type 1 thymidine kinase in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Acyclovir: discovery, mechanism of action, and selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: analysis of clinical isolates from herpetic keratitis patients and laboratory strains

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Characterization of Abnormal Thymidine Kinases Induced by Drug-resistant Strains of Herpes Simplex Virus Type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Role of genotypic analysis of the thymidine kinase gene of herpes simplex virus for determination of neurovirulence and resistance to acyclovir.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Occurrence and characterization of acyclovir‐resistant herpes simplex virus isolates: Report on a two—year sensitivity screening survey

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Purification and photoaffinity labeling of herpes simplex virus type-1 thymidine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

Investigation of aciclovir-resistant herpes simplex virus I infection in a bone marrow transplantation unit: genotyping shows that different strains are involved

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900263-9

7 January 2021

10.1016/S1386-6532(02)00263-9

Identifiers

DOI

1 reference

2 August 2017

1 reference